We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

21 hedge funds and large institutions have $2.46M invested in Coeptis Therapeutics Warrants in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more capital invested

Capital invested by funds: $1.81M → $2.46M (+$651K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

5% more funds holding

Funds holding: 20 → 21 (+1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
3
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$5.32K
2
Citadel Advisors
Citadel Advisors
Florida
+$920

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$208K
2
AA
AQR Arbitrage
Connecticut
-$21.6K
3
CAC
Cowen and Company
New York
-$21K
4
ICM
Ionic Capital Management
New York
-$3.25K
5
Walleye Capital
Walleye Capital
New York
-$47
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$749K – – –
AA
2
AQR Arbitrage
Connecticut
$650K -$21.6K -65,000 -50%
Citadel Advisors
3
Citadel Advisors
Florida
$195K +$920 +2,764 +0.5%
BFM
4
Boothbay Fund Management
New York
$150K – – –
BCM
5
Basso Capital Management
Connecticut
$149K – – –
ICM
6
Ionic Capital Management
New York
$136K -$3.25K -9,752 -2%
KC
7
Kepos Capital
New York
$81K – – –
OCAM
8
Owl Creek Asset Management
New York
$63K – – –
Wells Fargo
9
Wells Fargo
California
$49K – – –
RCM
10
Rivernorth Capital Management
Florida
$48K – – –
SCM
11
Shaolin Capital Management
Florida
$34K – – –
CF
12
Cantor Fitzgerald
New York
$34K +$35.4K +106,459 New
PC
13
Periscope Capital
Ontario, Canada
$29K – – –
Walleye Capital
14
Walleye Capital
New York
$28K -$47 -141 -0.2%
Walleye Trading
15
Walleye Trading
New York
$19K – – –
ICMH
16
Integrity Capital Management (HK)
Hong Kong
$18K +$18.2K +54,649 New
SM
17
Skaana Management
New York
$11K +$11.4K +34,180 New
CL
18
CSS LLC
Illinois
$7K – – –
KJHP
19
K.J. Harrison & Partners
Ontario, Canada
$5K – – –
PCM
20
Prelude Capital Management
New York
$5K – – –
VF
21
Virtu Financial
New York
$5K +$5.32K +15,972 New
GCL
22
Glazer Capital LLC
New York
– -$208K -803,312 Closed
CAC
23
Cowen and Company
New York
– -$21K -79,294 Closed

COEPW Hedge Fund Activity: Q4 2021 in Review

21 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2021, worth a combined $2.46M — up 36% from $1.81M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new COEPW positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $5.32K. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $208K sold.

  • 21 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2021, up from 20 in Q3 2021.
  • Funds reported $2.46M of Coeptis Therapeutics Warrants stock for Q4 2021, up 36% quarter-over-quarter.
  • 4 funds opened new Coeptis Therapeutics Warrants positions in Q4 2021 and 3 closed out, a net change of +1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q4 2021 was Virtu Financial, an estimated $5.32K added.
  • The largest Coeptis Therapeutics Warrants seller in Q4 2021 was Glazer Capital LLC, an estimated $208K sold.

Based on aggregated 13F filings for Q4 2021.